行車安全用藥分級課程介入在種子藥師認知、態度及行為改變之成效評估

Evaluating the effectiveness of driving medication safety training to improve pharmacists' knowledge, attitude, and behavior

10.6288/TJPH.202302_42(1).111076

鮑俊蓓(Jiunn-Bey Pao)；黃煒翔(Wei-Hsiang Huang)；鮑柏穎(Bo-Ying Bao)；吳淑娟(Shu-Chuan Wu)；劉潔心(Chieh-Hsing Liu)

藥師 ； 駕駛安全 ； 藥物使用 ； 健康信念模式 ； 教育介入 ； pharmacists ； driving safety ； medication use ； Health Belief Model (HBM) ； educational intervention

台灣公共衛生雜誌

42卷1期（2023 / 02 / 24）

117 - 129

繁體中文;英文

目標：本研究旨在探討行車安全用藥分級種子藥師教育課程介入後，評估此課程對藥師行車安全用藥分級之認知、態度與行為介入的成效。方法：本研究設計為運用健康信念模式（Health Belief Model, HBM）融入行車安全用藥分級種子藥師教育課程，並採用前、後測並追蹤延宕效果的準實驗研究設計。研究工具由研究者自編行車安全用藥分級宣導之現況評估問卷做為評量工具，建立效度、信度、難度與鑑別度。正式研究對象採便利取樣，選取臺北市與新北市藥師共60人，研究設計採對照組等待名單的方式進行。結果：以廣義估計方程式進行分析。結果發現當方程式控制了組別與時間之後，行車安全用藥分級種子藥師教育課程對於藥師的行車安全用藥分級認知、態度、行為皆有正向成效。結論：藥師須協助民眾處理複雜的用藥問題，讓藥物能安全的使用是藥師的職責。事先培育藥師具備行車安全用藥分級應有認知、態度與行為，能讓藥師有效的判斷駕駛使用藥物的風險，並與民眾或醫師進行溝通，提出最適當的用藥建議。期望能降低一般大眾在駕駛中的用藥風險與行車事故發生。

Objectives: This study investigated the use of the driving medication safety training curriculum and evaluated the effectiveness of this curriculum in promoting the knowledge, attitude, and behavior of pharmacists on classification of medication use and driving safety. Methods: This study was designed as a quasi-experimental study that integrated the health belief model into the driving medication safety training curriculum, and adopts with pre- and post-testing control group design as well as tracking of delayed effects. The researchers utilized a current state analysis questionnaire for the promotion of classification of medication use and driving safety as the evaluation tool. After a preliminary evaluation of the validity, reliability, difficulty, and discrimination were established. Sixty pharmacists in Taipei City and New Taipei City were selected as the formal research participants through convenience sampling. The study was conducted by following a waiting list control group design. Results: The study analysis was performed with generalized estimating equations. When the equation controlled for "group" and "time," the pharmacy education curriculum for the classification of medication use and driving safety had a positive effect on pharmacists' knowledge, attitude, and behavior. Conclusions: Pharmacists must assist the public in dealing with complex medication problems, and the onus of the safe use of medications is upon pharmacists. Pre-training pharmacists with the knowledge, attitude, and behaviors required for driving safety and medication use can enable them to effectively determine the risk of medication use and driving as well as communicate with the public or doctors to make the most appropriate drug recommendations. It is expected to reduce the risk of medication use while driving and the occurrence of traffic accidents in the general public.

1. 交通部公路總局統計查詢網：公路交通事故道安會統計表。https://stat.thb.gov.tw/hb01/webMain.aspx?sys=100&funid=defjsp。引用2022/09/12。 Highway Statistical Data Query, Directorate General of Highways, Ministry of Transportation and Communications, R.O.C. (Taiwan). Statistics of road traffic accidents compiled by the National Road Traffic Safety Commission. Available at: https://stat.thb.gov.tw/hb01/webMain.aspx?sys=100&funid=defjsp. Accessed September 12, 2022. [In Chinese]
2. 全國法規資料庫：道路交通管理處罰條例。https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=K0040012。引用2022/09/12。Laws & Regulations Database of the Republic of China. Road Traffic Management and Penalty Act. Available at: https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=K0040012. Accessed September 12, 2022
3. Brown, T,Milavetz, G,Murry, DJ(2013).Alcohol, drugs and driving: implications for evaluating driver impairment.Ann Adv Automot Med,57,23-32.
4. Brunnauer, A,Herpich, F,Zwanzger, P,Laux, G(2021).Driving performance under treatment of most frequently prescribed drugs for mental disorders: a systematic review of patient studies.Int J Neuropsychopharmacol,24,679-693.
5. Chang, CM,Wu, CH,Chen, CY(2013).Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study.Br J Clin Pharmacol,75,1125-1133.
6. Chien, IC,Bih, SH,Chou, YJ,Lin, CH,Lee, WG,Chou, P(2007).Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997-2004.Psychiatr Serv,58,554-557.
7. Crocker, L,Algina, J.Introduction to classical and modern test theory.
8. Davis, LL(1992).Instrument review: getting the most from a panel of experts.Appl Nurs Res,5,194-197.
9. Elliott, S,Brown, J(2002).What are we doing to waiting list controls?.Behav Res Ther,40,1047-1052.
10. French Health Products Safety Agency (Agence francoise de sécurité sanitaire des produits de santé, AFSSAPS). Medicinal products and driving. Available at: https://archiveansm.integra.fr/var/ansm_site/storage/original/application/e5f2e48d5344bcfef6ca865ac63e7c3d.pdf. Accessed September 12, 2022
11. Hasan, R,Watson, B,Haworth, N,Oviedo-Trespalacios, O(2022).A systematic review of factors associated with illegal drug driving.Accid Anal Prev,168,106574.
12. Hedlund, J.,未出版
13. International Pharmaceutical Federation=Fédération Internationale Pharmaceutique=FIP(2005).FIP statement of professional standards: the supply of medicines affecting driving performance.J Pain Palliat Care Pharmacother,19,55-57.
14. Iwata, M,Iwamoto, K,Kawano, N,Kawaue, T,Ozaki, N(2018).Evaluation method regarding the effect of psychotropic drugs on driving performance: a literature review.Psychiatry Clin Neurosci,72,747-773.
15. Jomaa, I,Odisho, M,Cheung, JM(2018).Pharmacists’ perceptions and communication of risk for alertness impairing medications.Res Social Adm Pharm,14,31-45.
16. Joorbonyan, H,Ghaffari, M,Rakhshanderou, S(2022).Peer-led theoretically desinged HIV/AIDS prevention intervention among students: a case of health belief model.BMC Public Health,22,8.
17. Kahaleh, AA,Truong, HA(2021).Applications of the health belief model and continuing professional development for emergency preparedness and response.Am J Pharm Educ,85,8376.
18. Karimzadeh, A,Leupold, F,Thielmann, A(2021).Optimizing blood pressure control by an Information Communication Technology-supported case management (PIA study): study protocol for a cluster-randomized controlled trial of a delegation model for general practices.Trials,22,738.
19. Liang, KY,Zeger, SL(1986).Longitudinal data analysis using generalized linear models.Biometrika,73,13-22.
20. Mahmoudi, L,Shafiekhani, M,Dehghanpour, H,Niknam, R(2019).Community pharmacists’ knowledge, attitude, and practice of Irritable Bowel Syndrome (IBS): the impact of training courses.Adv Med Educ Pract,10,427-436.
21. Nunnally, JC(1978).Psychometric Theory.New York, NY:McGraw-Hill.
22. Panahi, R,Siboni, FS,Kheiri, M,Ghoozlu, KJ,Shafaei, M,Dehghankar, L(2021).Promoting the adoption of behaviors to prevent osteoporosis using the health belief model integrated with health literacy: quasi-experimental intervention study.BMC Public Health,21,2221.
23. Rudisill, TM,Zhu, M,Kelley, GA,Pilkerton, C,Rudisill, BR(2016).Medication use and the risk of motor vehicle collisions among licensed drivers: a systematic review.Accid Anal Prev,96,255-270.
24. Sasanfar, B,Toorang, F,Rostami, S(2022).The effect of nutrition education for cancer prevention based on health belief model on nutrition knowledge, attitude, and practice of Iranian women.BMC Womens Health,22,213.
25. Walsh, JM,Gier, JJ,Christopherson, AS,Verstraete, AG(2004).Drugs and driving.Traffic Inj Prev,5,241-253.
26. WHO.Global status report on road safety 2018.
27. Wiedenmayer, K,Summers, RS,Mackie, CA(2006).Developing Pharmacy Practice: A Focus on Patient Care: Handbook.Geneva:WHO.
28. 吳明隆, ML,涂金堂, CT(2006).SPSS與統計應用分析.台北=Taipei:五南圖書出版公司=Wu-Nan Book Inc..
29. 國家衛生研究院=National Health Research Institute(2021).台灣鎮靜安眠藥不當使用之防治策略建言書.苗栗=Miaoli:國家衛生研究院=National Health Research Institute.
30. 衛生福利部統計處：民國109年死因結果摘要表。https://www.mohw.gov.tw/cp-5017-61533-1.html。引用2022/09/12。 Department of Statistics, Ministry of Health and Welfare, R.O.C. (Taiwan). The summary table of the cause of death statistics in 2020. Available at: https://www.mohw.gov.tw/cp-5017-61533-1.html. Accessed September 12, 2022. [In Chinese]